Annovis looks to advance pivotal Alzheimer’s and Parkinson’s drug studies
Pharmaceutical Technology
OCTOBER 25, 2023
The AD and PD drug aims to reduce the level of neurotoxic proteins, thereby improving information flow across the axonal transport
Wed.Oct 25, 2023
246 
Adults With ADHD at Greater Risk of Dementia, Study Shows
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 25, 2023
Adults diagnosed with attention-deficit/hyperactivity disorder ( ADHD) are almost three times more likely to go on to develop dementia, according to a new study that looked at 109,218 adults with and without the condition over a period of 17 years. The researchers, from institutions in Israel and the US, found that 13.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Eisai says new data could support more convenient form of Alzheimer’s drug Leqembi
Bio Pharma Dive
OCTOBER 25, 2023
An under-the-skin injection of Leqembi performed about the same as the already marketed intravenous form, according to trial results presented Wednesday. A new approval application is expected by the end of March.
ICMR releases consensus document for management of prostate cancer
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 25, 2023
The Division of Non Communicable Diseases (NCD) of the Indian Council of Medical Research (ICMR) has come out with a Consensus Document for Management of Prostate Cancer to equip clinicians and students on latest therapies.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Supply shortage hits infant RSV antibody Beyfortus
Bio Pharma Dive
OCTOBER 25, 2023
The CDC is asking doctors to ration supply of Sanofi and AstraZeneca’s new RSV drug Beyfortus, as demand has outstripped supply.
International initiative launched to create personalised cardiovascular care
Pharmaceutical Technology
OCTOBER 25, 2023
iCARE4CVD is coordinated by Novo Nordisk and aims to collect and analyse data from 1 million people to validate personalized treatments.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Local authorities in England are failing to meet dementia diagnosis targets
Pharma Times
OCTOBER 25, 2023
The APPG has called for urgent improvements in rural and ethnically diverse-areas - News - PharmaTimes
Amgen to lay off 350 Horizon staffers weeks after closing $28B deal
Bio Pharma Dive
OCTOBER 25, 2023
The latest round of cuts brings the company’s total announced workforce reductions this year to more than 1,000.
CpHI Europe: Quality improvements key for the surviving the generic drugs market
Pharmaceutical Technology
OCTOBER 25, 2023
Experts discuss the key trends in quality improvements and API reshoring for the generic drugs market at CpHI Europe.
Excision gives first look at gene editing therapy for HIV
Bio Pharma Dive
OCTOBER 25, 2023
The study results, while only from three participants, offer a glimpse at how one of the few in vivo CRISPR therapies in U.S. human testing is working.
AxoSim acquires microBrain technology to build neurological drug pipeline
Pharmaceutical Technology
OCTOBER 25, 2023
AxoSim’s microBrain drug discovery platform acquisition includes a US manufacturing facility, and associated patents and IP.
[Podcast] Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity
Bio Pharma Dive
OCTOBER 25, 2023
This podcast series explores how life sciences companies can bolster their cybersecurity while growing their business.
FDA grants clearance for Endogena’s age-related macular degeneration treatment
Pharma Times
OCTOBER 25, 2023
The company will launch a clinical investigation of EA-2351 for geographic atrophy - News - PharmaTimes
Sitravatinib malate by Mirati Therapeutics for Metastatic Melanoma: Likelihood of Approval
Pharmaceutical Technology
OCTOBER 25, 2023
Sitravatinib malate is under clinical development by Mirati Therapeutics and currently in Phase II for Metastatic Melanoma.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
AI in wound: Delivering advanced care through a national wound registry
pharmaphorum
OCTOBER 25, 2023
AI in wound: Delivering advanced care through a national wound registry Mike.
Sitravatinib malate by Mirati Therapeutics for Metastatic Melanoma: Likelihood of Approval
Pharmaceutical Technology
OCTOBER 25, 2023
Sitravatinib malate is under clinical development by Mirati Therapeutics and currently in Phase II for Metastatic Melanoma.
Health Innovators – Melissa Little
pharmaphorum
OCTOBER 25, 2023
Melissa Little is CEO of the Novo Nordisk Foundation Centre for Stem Cell Medicine, or reNEW
Aiolos launches with $245m Series A to advance asthma therapies
Pharmaceutical Technology
OCTOBER 25, 2023
Aiolos will lead the anti-TSLP antibody into Phase II clinical trials after demonstrating high potency in Phase I study.
After FDA found misconduct at trial site, BioXcel touts result from third-party audit and eyes filing
Fierce Pharma
OCTOBER 25, 2023
After misconduct at a key trial site raised questions of | The FDA previously uncovered evidence of forged emails and trial misconduct in the company's phase 3 Alzheimer's disease agitation study. Now, with a third-party audit in hand, BioXcel looks to push forward with the drug.
Insmed and Google Cloud enter AI drug development deal
Pharmaceutical Technology
OCTOBER 25, 2023
Insmed and Google Cloud have partnered to leverage generative AI for transforming the discovery, development and marketing of drugs.
ESMO: J&J’s Tagrisso challenge, and other highlights
pharmaphorum
OCTOBER 25, 2023
ESMO: J&J’s Tagrisso challenge, and other highlights Phil.
Novartis reports 14% growth in Q3 2023 net income
Pharmaceutical Technology
OCTOBER 25, 2023
Novartis has posted net income of $1.51bn in the third quarter (Q3) of 2023, a 14% rise compared to $1.33bn in the same quarter of 2022.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
List of research papers citing DrugPatentWatch
Drug Patent Watch
OCTOBER 25, 2023
DrugPatentWatch has published a list of research papers citing DrugPatentWatch at [link] DrugPatentWatch.com is your key to unlocking the world of pharmaceutical research. These primary literature citations can benefit researchers,… The post List of research papers citing DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions.
DermBiont raises $35.2m in Series B for dermatological therapies
Pharmaceutical Technology
OCTOBER 25, 2023
The funds will go towards Phase II trials for the company’s two candidates treating seborrheic keratoses and melasma.
Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71% for FY2023
BioSpace
OCTOBER 25, 2023
Attributing losses to exchange rate and pipeline impairment losses, the Japanese biopharma dropped its reported net profit forecast of 142 billion yen ($945.1 million) to 93 billion yen ($618.8 million).
Blockchain-based app to detect fraudulent medicines unveiled in Copenhagen
Pharmaceutical Technology
OCTOBER 25, 2023
A blockchain system intended to ensure the safety and authenticity of medicines across the supply chain could change the way that medical professionals work, as discussed at the 11th Annual Clinical Trial Supply Nordics conference.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
On heels of FDA approval, trial results set up GSK's RSV vaccine for label expansion
Fierce Pharma
OCTOBER 25, 2023
Five months after becoming the first company to secure FDA approval for a respiratory syncytial virus (RSV) vaccine, GSK is taking steps toward expanding its label for Arexvy. | Five months after becoming the first company to secure FDA approval for a respiratory syncytial virus (RSV) vaccine, GSK is taking steps toward expanding its label for Arexvy.
BMS gains breakthrough therapy designation for PPF treatment
Pharmaceutical Technology
OCTOBER 25, 2023
BMS has received breakthrough therapy designation from the US FDA for its investigational therapy BMS-986278 to treat PPF.
Roche, Biogen quickly settle patent lawsuit over biosimilar of arthritis med Actemra
Fierce Pharma
OCTOBER 25, 2023
That didn’t take long. Roche has already settled a patent infringement lawsuit that it filed against Biogen in July. | Roche has already settled a patent infringement lawsuit that it filed against Biogen in July. The case surrounded Biogen’s biosimilar version of Roche’s blockbuster rheumatoid arthritis therapy Actemra.
FDA approves Servier’s Tibsovo for myelodysplastic syndromes
Pharmaceutical Technology
OCTOBER 25, 2023
The US FDA has granted approval for Servier’s Tibsovo to treat IDH1-mutated relapsed or refractory (R/R) myelodysplastic syndromes (MDS).
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content